Imidapril Attenuates Matrix Metalloproteinase-9 Activity More Efficiently than Losartan in Patients with Acute Myocardial Infarction

被引:0
|
作者
Hoshiga, Masaaki
Miyamoto, Hiroyuki
Hazui, Hiroshi
Takai, Shinji
Mori, Toshizumi
Oishi, Yasuo
Ishihara, Tadashi
Hanafusa, Toshiaki
机构
[1] Osaka Med Coll, Osaka, Japan
[2] Osaka Mishima Emergency & Crit Care Cntr, Osaka, Japan
关键词
ACE inhibitor; Angiotensin II; Myocardial infarction;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A12141
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Serum matrix metalloproteinase-9 levels in patients with acute myocardial infarction
    Guzel, Savas
    Serin, Ozden
    Yilmaz, Guzin
    Guzel, Eda Celik
    Guvenen, Guvenc
    CLINICAL BIOCHEMISTRY, 2009, 42 (4-5) : 342 - 342
  • [2] Matrix metalloproteinase-9 polymorphism and outcome after acute myocardial infarction
    Abd El-Aziz, Tarek A.
    Mohamed, Rasha H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 524 - 528
  • [3] Plasma matrix metalloproteinase-9 originates from the vulnerable plaque in patients with acute myocardial infarction
    Higo, S
    Nanto, S
    Uematsu, M
    Ohara, T
    Kotani, JI
    Nishio, M
    Awata, M
    Lida, O
    Nagata, S
    Yamagishi, M
    CIRCULATION, 2003, 108 (17) : 415 - 415
  • [4] Myocardial Injury Promotes Matrix Metalloproteinase-9 Activity in the Renal Cortex in Preclinical Models of Acute Myocardial Infarction
    Qiao, Xiaoying
    Bhave, Shreyas
    Swain, Lija
    Zweck, Elric
    Reyelt, Lara
    Crowley, Paige
    Annamalai, Shiva K.
    Chennjorwala, Aditya
    Esposito, Michele
    Razavi, Allen
    Foroutanjazi, Sina
    Machen, Cody
    Thayer, Katherine
    Jorde, Lena
    Karas, Richard H.
    Kapur, Navin K.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (02) : 207 - 216
  • [5] Myocardial Injury Promotes Matrix Metalloproteinase-9 Activity in the Renal Cortex in Preclinical Models of Acute Myocardial Infarction
    Xiaoying Qiao
    Shreyas Bhave
    Lija Swain
    Elric Zweck
    Lara Reyelt
    Paige Crowley
    Shiva K. Annamalai
    Aditya Chennjorwala
    Michele Esposito
    Allen Razavi
    Sina Foroutanjazi
    Cody Machen
    Katherine Thayer
    Lena Jorde
    Richard H. Karas
    Navin K. Kapur
    Journal of Cardiovascular Translational Research, 2022, 15 : 207 - 216
  • [6] Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction
    Wagner, DR
    Delagardelle, C
    Ernens, I
    Rouy, D
    Vaillant, M
    Beissel, J
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) : 66 - 72
  • [7] Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters
    Takai, Shinji
    Yamamoto, Daisuke
    Jin, Denan
    Inagaki, Sachiko
    Yoshikawa, Katsuhiro
    Tanaka, Kazuhiko
    Miyazaki, Mizuo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 568 (1-3) : 231 - 233
  • [8] Matrix Metalloproteinase-9 may be a new biomarker for coronary plaque rupture in patients with acute myocardial infarction
    funayama, Hiroshi
    Ishikawa, San-e
    Yasu, Takanori
    Kubo, Norifumi
    Momomura, Shinichi
    Kawakami, Masanobu
    CIRCULATION, 2006, 114 (18) : 783 - 783
  • [9] Chymase Inhibition Reduces Infarction and Matrix Metalloproteinase-9 Activation and Attenuates Inflammation and Fibrosis after Acute Myocardial Ischemia/Reperfusion
    Oyamada, Shizu
    Bianchi, Cesario
    Takai, Shinji
    Chu, Louis M.
    Sellke, Frank W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (01): : 143 - 151
  • [10] Expression of serum matrix metalloproteinase-2 and plasma matrix metalloproteinase-9 in patients with acute myocardial infarction who underwent successful reperfusion
    Nakaya, R
    Lee, JD
    Shimizu, H
    Nakano, A
    Mitsuke, Y
    Yamazaki, T
    Ueda, T
    CIRCULATION, 2002, 106 (19) : 528 - 528